Cardinal Health, Inc. (NYSE:CAH) Shares Sold by PGGM Investments

PGGM Investments reduced its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 0.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 168,696 shares of the company’s stock after selling 343 shares during the quarter. PGGM Investments’ holdings in Cardinal Health were worth $17,005,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Cornerstone Wealth Management LLC acquired a new stake in Cardinal Health during the 4th quarter valued at $209,000. Nordea Investment Management AB raised its stake in Cardinal Health by 50.5% during the 4th quarter. Nordea Investment Management AB now owns 184,537 shares of the company’s stock valued at $18,649,000 after purchasing an additional 61,933 shares during the period. Vest Financial LLC raised its stake in Cardinal Health by 15.9% during the 4th quarter. Vest Financial LLC now owns 282,440 shares of the company’s stock valued at $28,470,000 after purchasing an additional 38,769 shares during the period. Bellwether Advisors LLC acquired a new stake in Cardinal Health during the 4th quarter valued at $6,290,000. Finally, DekaBank Deutsche Girozentrale raised its stake in Cardinal Health by 30.1% during the 4th quarter. DekaBank Deutsche Girozentrale now owns 547,525 shares of the company’s stock valued at $54,618,000 after purchasing an additional 126,668 shares during the period. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Trading Down 0.6 %

Cardinal Health stock traded down $0.60 during mid-day trading on Friday, hitting $103.21. 1,399,916 shares of the company’s stock were exchanged, compared to its average volume of 1,705,735. The stock has a market cap of $25.10 billion, a P/E ratio of 40.63, a P/E/G ratio of 1.05 and a beta of 0.68. Cardinal Health, Inc. has a 1-year low of $77.56 and a 1-year high of $116.04. The stock has a 50 day moving average of $109.51 and a two-hundred day moving average of $104.67.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, February 1st. The company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.56 by $0.26. Cardinal Health had a net margin of 0.30% and a negative return on equity of 57.44%. The firm had revenue of $57.45 billion for the quarter, compared to the consensus estimate of $57.02 billion. During the same period in the prior year, the business posted $1.32 earnings per share. The business’s quarterly revenue was up 11.6% on a year-over-year basis. As a group, research analysts predict that Cardinal Health, Inc. will post 7.28 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were issued a dividend of $0.5006 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.94%. The ex-dividend date was Thursday, March 28th. Cardinal Health’s dividend payout ratio (DPR) is 78.74%.

Analysts Set New Price Targets

Several brokerages have issued reports on CAH. Leerink Partnrs reissued an “outperform” rating on shares of Cardinal Health in a research note on Monday, February 26th. StockNews.com downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Wednesday. SVB Leerink initiated coverage on shares of Cardinal Health in a research note on Monday, February 26th. They issued an “outperform” rating and a $125.00 price target on the stock. UBS Group upped their price target on shares of Cardinal Health from $122.00 to $125.00 and gave the stock a “buy” rating in a research note on Monday, February 5th. Finally, Barclays initiated coverage on shares of Cardinal Health in a research note on Wednesday, January 3rd. They issued an “overweight” rating and a $117.00 price target on the stock. One analyst has rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $103.07.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.